As of 3:59pm ET
| +0.20 / +8.89%|
The 1 analysts offering 12-month price forecasts for Acasti Pharma Inc have a median target of 14.90, with a high estimate of 14.90 and a low estimate of 14.90. The median estimate represents a +508.26% increase from the last price of 2.45.
The current consensus among 1 polled investment analysts is to Buy stock in Acasti Pharma Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.